1 terminated. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Histiocytoma: new trials by email Literature Review of Histiocytoma trials Research Report on Histiocytoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma doxorubicin hydrochloride, trabectedin, laboratory biomarker analysis - Sarcoma | Phase 2 / Phase 3 | Terminated | European Organisation for Research and Treatment of Cancer - EORTC | 133 | 2011-05-01 | 2014-08-08 |
Chondrosarcoma, Extraskeletal Myxoid (1) · Desmoplastic Small Round Cell Tumor (1) · Fibrosarcoma (1) · Hemangiopericytoma, Malignant (1) · Hemangiosarcoma (1) · Histiocytoma, Malignant Fibrous (1) · Leiomyosarcoma (1) · Malignant mesenchymal tumor (1) · Neurofibrosarcoma (1) · Sarcoma (1) · Sarcoma, Alveolar Soft Part (1) · Sarcoma, Synovial (1)
Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Connective Tissue (1) · Neoplasms, Connective and Soft Tissue (1) · Neoplasms, Fibrous Tissue (1) · Neoplasms, Muscle Tissue (1) · Neoplasms, Nerve Tissue (1) · Neoplasms, Vascular Tissue (1) · Nerve Sheath Neoplasms (1) · Nervous System Diseases (1) · Nervous System Neoplasms (1) · Neurofibroma (1) · Neuromuscular Diseases (1) · Peripheral Nervous System Diseases (1)
Doxorubicin (1) · Trabectedin (1)
European Organisation for Research and Treatment of Cancer - EORTC (1)
Austria (1) · Belgium (1) · Denmark (1) · France (1) · Germany (1) · Hungary (1) · Netherlands (1) · Poland (1) · Slovakia (1) · Spain (1) · Switzerland (1) · United Kingdom (1) · United States (1)
James E. Butrynski, MD (1) · Nguyen Binh Bui, MD (1)
2009 (1)